CIPROFLOXACIN THERAPY OF INFECTIONS CAUSED BY PSEUDOMONAS-AERUGINOSA AND OTHER RESISTANT-BACTERIA

被引:51
作者
ERON, LJ
HARVEY, L
HIXON, DL
PORETZ, DM
机构
关键词
D O I
10.1128/AAC.28.2.308
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:308 / 310
页数:3
相关论文
共 10 条
[1]   TOBRAMYCIN SULFATE - SUMMARY OF WORLDWIDE EXPERIENCE FROM CLINICAL-TRIALS [J].
BENDUSH, CL ;
WEBER, R .
JOURNAL OF INFECTIOUS DISEASES, 1976, 134 :S219-S234
[2]   A MULTICLINIC RANDOMIZED STUDY OF THE COMPARATIVE EFFICACY, SAFETY AND TOLERANCE OF IMIPENEM CILASTATIN AND MOXALACTAM [J].
CALANDRA, GB ;
HESNEY, M ;
GRAD, C .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1984, 3 (05) :478-487
[3]   USE OF CEFTAZIDIME IN THE THERAPY OF SERIOUS INFECTIONS, INCLUDING THOSE DUE TO MULTIRESISTANT ORGANISMS [J].
CLUMECK, N ;
VANLAETHEM, Y ;
GORDTS, B ;
JASPAR, N ;
BUTZLER, JP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (02) :176-180
[4]   CEFTAZIDIME IN PATIENTS WITH PSEUDOMONAS INFECTIONS [J].
ERON, LJ ;
PARK, CH ;
HIXON, DL ;
GOLDENBERG, RI ;
PORETZ, DM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 12 :161-169
[5]   PIPERACILLIN THERAPY FOR PSEUDOMONAS INFECTIONS [J].
ERON, LJ ;
GOLDENBERG, RI ;
PORETZ, DM ;
PARK, CH .
SOUTHERN MEDICAL JOURNAL, 1983, 76 (07) :859-862
[6]   INVITRO ACTIVITIES OF NORFLOXACIN AND CIPROFLOXACIN AGAINST MYCOBACTERIUM-TUBERCULOSIS, MYCOBACTERIUM-AVIUM COMPLEX, M-CHELONEI, MYCOBACTERIUM-FORTUITUM, AND MYCOBACTERIUM-KANSASII [J].
GAY, JD ;
DEYOUNG, DR ;
ROBERTS, GD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (01) :94-96
[7]   CLINICAL-EXPERIENCE WITH MOXALACTAM IN THE TREATMENT OF PSEUDOMONAL AND NON-PSEUDOMONAL INFECTIONS [J].
MURPHY, TF ;
BARZA, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (04) :568-574
[8]   MOXALACTAM THERAPY OF INFECTIONS CAUSED BY CEPHALOTHIN-RESISTANT BACTERIA - INFLUENCE OF SERUM INHIBITORY ACTIVITY ON CLINICAL-RESPONSE AND ACQUISITION OF ANTIBIOTIC-RESISTANCE DURING THERAPY [J].
PLATT, R ;
EHRLICH, SL ;
AFARIAN, J ;
OBRIEN, TF ;
PENNINGTON, JE ;
KASS, EH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 20 (03) :351-355
[9]   CLINICAL-TRIAL OF PIPERACILLIN WITH ACQUISITION OF RESISTANCE BY PSEUDOMONAS AND CLINICAL RELAPSE [J].
SIMON, GL ;
SNYDMAN, DR ;
TALLY, FP ;
GORBACH, SL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (01) :167-170
[10]   INVITRO ACTIVITY OF BAY-09867, A NEW QUINOLINE DERIVATIVE, COMPARED WITH THOSE OF OTHER ANTI-MICROBIAL AGENTS [J].
WISE, R ;
ANDREWS, JM ;
EDWARDS, LJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (04) :559-564